Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia
In 1996, British Columbia, Canada, introduced universal coverage of drug and other health-care costs for people with HIV/AIDS and began extensive scale-up in access to ART. We aimed to assess the cost-effectiveness of ART scale-up in British Columbia compare dwith hypothetical scenarios of constrained treatment access.
OpenSource: The Lancet